Viewing Study NCT03098550


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2026-01-08 @ 10:19 PM
Study NCT ID: NCT03098550
Status: COMPLETED
Last Update Posted: 2021-07-23
First Post: 2017-03-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancer (NSCLC) View
None Triple Negative Breast Cancer (TNBC) View
None Pancreatic Cancer (PAC) View